Stephen Balk
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 6
- Radiation Therapy and Dosimetry 1
-
- Hormonal and reproductive studies 2
- Co-authors
- Elahe A. Mostaghel (2 shared papers)Stephen R. Plymate (2 shared papers)Peter S. Nelson (2 shared papers)Robert L. Vessella (1 shared paper)Glenn J. Bubley (5 shared papers)Brett T. Marck (1 shared paper)Bruce Montgomery (1 shared paper)Alvin M. Matsumoto (1 shared paper)
- Journals
- Clinical Cancer Research (1 paper)The Prostate (1 paper)Cancers (1 paper)European Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesSouth AfricaEgypt
In The Last Decade
Stephen Balk
8 papers receiving 992 citations
Stephen Balk's Hit Papers
Peers
Comparison fields: 5 of 58
- Cancer Research 387
- Pulmonary and Respiratory Medicine 675
- Endocrinology, Diabetes and Metabolism 242
- Genetics 167
- Molecular Biology 366
Countries citing papers authored by Stephen Balk
This map shows the geographic impact of Stephen Balk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Balk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Balk more than expected).
Fields of papers citing papers by Stephen Balk
This network shows the impact of papers produced by Stephen Balk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Balk. The network helps show where Stephen Balk may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Balk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants Hit paper breakdown → | 2011 | 475 |
| 2 | Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. | 2003 | 231 |
| 3 | Functional characterization of mutant androgen receptors from androgen-independent prostate cancer. | 1997 | 185 |
| 4 | 2007 | 44 | |
| 5 | 2017 | 33 | |
| 6 | 2004 | 31 | |
| 7 | 2008 | 4 | |
| 8 | 2014 | 1 |
About Stephen Balk
Stephen Balk is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 1.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Estrogen and related hormone effects (2 papers), Hormonal and reproductive studies (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), High Altitude and Hypoxia (1 paper), Radiation Therapy and Dosimetry (1 paper) and Sexual Differentiation and Disorders (1 paper). The work is most often cited by research in Cancer Research (387 citations), Pulmonary and Respiratory Medicine (675 citations), Endocrinology, Diabetes and Metabolism (242 citations), Genetics (167 citations) and Molecular Biology (366 citations). Stephen Balk has collaborated with scholars based in United States, South Africa and Egypt. Frequent co-authors include Elahe A. Mostaghel, Stephen R. Plymate, Peter S. Nelson, Robert L. Vessella, Glenn J. Bubley, Brett T. Marck, Bruce Montgomery, Alvin M. Matsumoto, Mary Ellen Taplin and Phillip G. Febbo. Their work appears in journals such as Clinical Cancer Research, The Prostate, Cancers, European Journal of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.